Albemarle Corporation

New York Stock Exchange
Back to all articles
Slightly Bullish +25

Bank of New York Mellon Corp Cuts Position in Albemarle Corporation ...

AI-generated analysis

📉 Bank of New York Mellon Corp trimmed its Albemarle position by 3.6% in Q1, selling 32,106 shares while retaining a stake valued at $154 million.

📈 Smaller institutional investors like BOKF NA and EverSource Wealth Advisors significantly boosted their stakes, with BOKF increasing holdings by over 5,700%.

📊 Mizuho Financial Group lowered its price target on Albemarle from $205 to $185 and assigned a neutral rating in a recent report.

📉 Jefferies Financial Group reduced its price objective from $244 to $211 but maintained a buy rating for the specialty chemicals company.

📈 HSBC raised its target price on Albemarle shares from $200 to $220 and reaffirmed a buy rating in an April research note.

📉 Scotiabank increased its price target from $200 to $215, issuing an outperform rating for the company in May.

📉 Robert W. Baird decreased its price target from $236 to $224 and set a neutral rating on June 18th.

🏆 The consensus analyst rating is Moderate Buy with an average price target of $200.52, supported by fifteen buy ratings against ten holds.

💰 CEO J Kent Masters sold 16,393 shares for approximately $3 million on May 15th, reducing his direct ownership by 15.78%.

📈 Albemarle reported Q1 earnings of $2.95 EPS, beating the consensus estimate of $1.24 by a wide margin of $1.71.

💵 Revenue for the quarter reached $1.43 billion, up 32.7% year-over-year against analyst estimates of $1.34 billion.

📉 The company reported a negative net margin of 5.00% but maintained a positive return on equity of 5.22%.

💸 A quarterly dividend of $0.405 per share was paid to investors of record on June 12th, representing a 1.3% yield.

🏢 The company has a market cap of $14.25 billion and a low debt-to-equity ratio of 0.23 indicating strong financial leverage.

📉 Stock price volatility is evident with the share trading between a one-year low of $64.95 and a high of $221.00.

Bullish Signals
  • Albemarle reported Q1 earnings of $2.95 EPS, significantly beating the consensus estimate of $1.24 by $1.71.
  • Revenue surged to $1.43 billion for the quarter, representing a robust 32.7% year-over-year increase.
  • The company maintained a positive return on equity of 5.22% despite a negative net margin.
  • HSBC raised its price target from $200 to $220 and issued a buy rating for the stock.
  • Scotiabank increased its price target from $200 to $215 with an outperform rating.
  • The company declared a quarterly dividend of $0.405 per share, providing income to shareholders.
  • Albemarle maintains a strong balance sheet with a low debt-to-equity ratio of 0.23.
  • Institutional ownership remains high at 92.87%, indicating continued confidence from major funds.
Risk Factors
  • Mizuho Financial Group lowered its price target on Albemarle from $205 to $185 and set a neutral rating.
  • Jefferies Financial Group reduced its price objective from $244 to $211, citing lower valuation expectations.
  • Robert W. Baird decreased its price target from $236 to $224 and assigned a neutral rating.
  • CEO J Kent Masters sold 16,393 shares for over $3 million, reducing his direct ownership stake by 15.78%.
  • The company reported a negative net margin of 5.00%, indicating profitability challenges in the current quarter.
  • Bank of New York Mellon Corp reduced its position in Albemarle by 3.6% during the first quarter.
Full Analysis
Bank of New York Mellon Corp reduced its position in Albemarle Corporation (NYSE:ALB) by 3.6% in the first quarter, selling 32,106 shares to hold a remaining stake worth $154 million. While major institutions trimmed stakes, smaller funds like BOKF NA and EverSource Wealth Advisors significantly increased their holdings, with institutional ownership standing at 92.87%. The article details a mixed landscape of analyst sentiment, ranging from Mizuho's downgrade to neutral and Jefferies' lower price target, alongside positive upgrades from HSBC and Scotiabank. Albemarle reported strong quarterly financial results on May 6th, posting $2.95 in earnings per share which significantly beat the consensus estimate of $1.24. Revenue reached $1.43 billion, representing a 32.7% year-over-year increase compared to analyst expectations of $1.34 billion. Despite the negative net margin of 5.00%, the company maintained a positive return on equity of 5.22% and declared a quarterly dividend of $0.405 per share, paid on July 1st. CEO J Kent Masters executed a significant insider sale on May 15th, selling 16,393 shares at an average price of $183.72 for a total value exceeding $3 million. This transaction resulted in a 15.78% decrease in his direct ownership, leaving him with approximately 87,519 shares valued at roughly $16 million. The company maintains a market capitalization of $14.25 billion and a debt-to-equity ratio of 0.23, reflecting its solid balance sheet structure amidst volatile stock price movements.